A within-subject analysis of carbamazepine disposition related to development in children with epilepsy

Fiorenzo Albani, Roberto Riva, Manuela Contin, Agostino Baruzzi

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The effect of aging on carbamazepine (CBZ) plasma level/dose ratio was evaluated retrospectively in 15 children who were receiving CBZ monotherapy and who were followed up for at least 3 years. Subjects of the study were selected from a population of roughly 4,500 patients attending our therapeutic drug monitoring service during a 12-year period. Results showed that the CBZ plasma level/dose ratio increases within subject during childhood, in agreement with data obtained in between-patient studies. However, the increase is not linear with age, the greatest modifications being observed between 9 and 13 years of age. Weight gain alone does not seem to explain this finding, implicating the involvement of complex physiological changes occurring during puberty.

Original languageEnglish
Pages (from-to)457-460
Number of pages4
JournalTherapeutic Drug Monitoring
Volume14
Issue number6
Publication statusPublished - 1992

Fingerprint

Carbamazepine
Child Development
Epilepsy
Plasmas
Drug Monitoring
Puberty
Weight Gain
Aging of materials
Monitoring
Pharmaceutical Preparations
Population

Keywords

  • Carbamazepine
  • Children
  • Epilepsy

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Health, Toxicology and Mutagenesis
  • Public Health, Environmental and Occupational Health
  • Toxicology

Cite this

A within-subject analysis of carbamazepine disposition related to development in children with epilepsy. / Albani, Fiorenzo; Riva, Roberto; Contin, Manuela; Baruzzi, Agostino.

In: Therapeutic Drug Monitoring, Vol. 14, No. 6, 1992, p. 457-460.

Research output: Contribution to journalArticle

@article{d41bef9d13274e4e820f56a6143a85e0,
title = "A within-subject analysis of carbamazepine disposition related to development in children with epilepsy",
abstract = "The effect of aging on carbamazepine (CBZ) plasma level/dose ratio was evaluated retrospectively in 15 children who were receiving CBZ monotherapy and who were followed up for at least 3 years. Subjects of the study were selected from a population of roughly 4,500 patients attending our therapeutic drug monitoring service during a 12-year period. Results showed that the CBZ plasma level/dose ratio increases within subject during childhood, in agreement with data obtained in between-patient studies. However, the increase is not linear with age, the greatest modifications being observed between 9 and 13 years of age. Weight gain alone does not seem to explain this finding, implicating the involvement of complex physiological changes occurring during puberty.",
keywords = "Carbamazepine, Children, Epilepsy",
author = "Fiorenzo Albani and Roberto Riva and Manuela Contin and Agostino Baruzzi",
year = "1992",
language = "English",
volume = "14",
pages = "457--460",
journal = "Therapeutic Drug Monitoring",
issn = "0163-4356",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - A within-subject analysis of carbamazepine disposition related to development in children with epilepsy

AU - Albani, Fiorenzo

AU - Riva, Roberto

AU - Contin, Manuela

AU - Baruzzi, Agostino

PY - 1992

Y1 - 1992

N2 - The effect of aging on carbamazepine (CBZ) plasma level/dose ratio was evaluated retrospectively in 15 children who were receiving CBZ monotherapy and who were followed up for at least 3 years. Subjects of the study were selected from a population of roughly 4,500 patients attending our therapeutic drug monitoring service during a 12-year period. Results showed that the CBZ plasma level/dose ratio increases within subject during childhood, in agreement with data obtained in between-patient studies. However, the increase is not linear with age, the greatest modifications being observed between 9 and 13 years of age. Weight gain alone does not seem to explain this finding, implicating the involvement of complex physiological changes occurring during puberty.

AB - The effect of aging on carbamazepine (CBZ) plasma level/dose ratio was evaluated retrospectively in 15 children who were receiving CBZ monotherapy and who were followed up for at least 3 years. Subjects of the study were selected from a population of roughly 4,500 patients attending our therapeutic drug monitoring service during a 12-year period. Results showed that the CBZ plasma level/dose ratio increases within subject during childhood, in agreement with data obtained in between-patient studies. However, the increase is not linear with age, the greatest modifications being observed between 9 and 13 years of age. Weight gain alone does not seem to explain this finding, implicating the involvement of complex physiological changes occurring during puberty.

KW - Carbamazepine

KW - Children

KW - Epilepsy

UR - http://www.scopus.com/inward/record.url?scp=0026446412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026446412&partnerID=8YFLogxK

M3 - Article

C2 - 1485365

AN - SCOPUS:0026446412

VL - 14

SP - 457

EP - 460

JO - Therapeutic Drug Monitoring

JF - Therapeutic Drug Monitoring

SN - 0163-4356

IS - 6

ER -